Concepedia

Ho Cho

HC

Statistics

Publications

7

Citations

881

H-Index

7

Active since

1990

Affiliations

Ambrx (United States)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Scripps Research Institute

Ho Cho is an author at Ambrx (United States) specializing in protein engineering, pharmacology, and life sciences.

ORCID

Publications per year

1990–2024

7

Publications

7

A general approach to site-specific antibody drug conjugates

Feng Tian, Yingchun Lu, Anthony Manibusan et al. · Proceedings of the National Academy of Sciences · 2014 · 317 citations · Full text

, , +17

Optimized clinical performance of growth hormone with an expanded genetic code

Ho Cho, T. Sheidy Daniel, Ying J. Buechler et al. · Proceedings of the National Academy of Sciences · 2011 · 198 citations · Full text

, , +16

New strategy for selective protein cleavage

Ho Cho, Peter G. Schultz · Journal of the American Chemical Society · 1990 · 135 citations

, , +5

In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates

Dowdy Jackson, John Atkinson, Claudia Guevara et al. · PLoS ONE · 2014 · 119 citations · Full text

, , +17

Structure of the human marker of self 5-transmembrane receptor CD47

Gustavo Fenalti, Nicolas Villanueva, Mark T. Griffith et al. · Nature Communications · 2021 · 52 citations · Full text

, , +17

1–5 of 7